The COVID-19 pandemic has stimulated intense efforts to find effective therapeutics for all
stages of the disease. Unfortunately, the scope, scientific rigour and clinical value of …

COVID-19 has rapidly developed into a worldwide pandemic with a significant health and
economic burden. There are currently no approved treatments or preventative therapeutic …

The COVID-19 pandemic has created massive disruptions to clinical trial research across
the world. As in other aspects of life, the virus has severely affected the ability to conduct …

Importance The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …

Background Since the outbreak of coronavirus disease 2019 (COVID-19), many researchers
in China have performed related clinical research. However, systematic reviews of the …

Despite the millions of cases and hundreds of thousands of deaths that have occurred in this
devastating coronavirus disease 2019 (COVID-19) pandemic, no peer-reviewed studies of …

The COVID-19 pandemic: a catalyst to improve clinical trials | Nature Reviews Cardiology Skip to
main content Thank you for visiting nature.com. You are using a browser version with limited …

Emerging coronavirus disease 2019, known as COVID-19, is caused by the newly identified
SARS-CoV-2 virus. Since the outbreak of COVID-19 in December 2019 in Wuhan (China) …

Background: Never before have clinical trials drawn as much public attention as those
testing interventions for COVID-19. We aimed to describe the worldwide COVID-19 clinical …

The emergence of SARS-CoV-2 triggering the COVID-19 pandemic ranks as arguably the
greatest medical emergency of the last century. COVID-19 has highlighted health disparities …